Skip to content

因文蒂瓦

US · IVA #3421 按市值排名 上市于 2020
2.94 -0.17 -5.47%
实时 - 追踪5344个代码 - 心跳于47秒前 · 2026-10-16 19:53

✦ 量化财务健康度 计算方式说明

偏弱
  • 奥特曼 Z 值为-1.42,低于1.8的"危险区"阈值。
  • 该模型对工业和制造业公司最为可靠,对银行、保险等金融类公司参考意义较弱。

营收 年度数据,近8年

最近年度同比-51.26%

利润率

营业利润率
-2,964.15%
净利率
-7,899.58%

关键比率与质量指标

奥特曼 Z 值低于约1.8提示财务困境风险,高于约3.0提示风险较低;该模型对工业和制造业公司最为可靠,对银行等金融类公司参考意义较弱。

利润表

项目 2018 2019 2020 2021 2022 2023 2024 2025
营收 3.20M7.00M372.00K4.19M12.18M17.48M9.20M4.48M
毛利润 ----------------
销售及管理费用 6.09M5.94M8.88M11.34M15.28M15.61M17.10M53.89M
研发费用 31.76M33.79M23.72M48.45M60.47M110.01M90.88M87.04M
营业利润 -30.65M-29.22M-26.55M-51.17M-56.86M-102.67M-93.99M-132.88M
税前利润 -33.02M-30.22M-33.62M-49.28M-54.29M-109.82M-183.90M-354.11M
税费 000364.00K-20.00K607.00K313.00K22.00K
净利润 -33.02M-30.22M-33.62M-49.64M-54.27M-110.43M-184.21M-354.14M
基本每股收益 -2-1-1-1-1-2-3-2
稀释每股收益 -1.61-1.28-0.99-1.27-1.31-2.43-3.08-1.90

资产负债表

项目 2018 2019 2020 2021 2022 2023 2024 2025
流动资产总额 71.63M48.88M133.00M115.58M106.38M48.19M111.51M244.47M
现金及短期投资 56.69M35.84M113.02M95.38M87.79M26.99M96.56M230.87M
存货 410.00K387.00K320.00K392.00K373.00K417.00K00
总资产 79.81M56.96M138.92M121.99M116.00M69.56M118.97M249.51M
流动负债总额 15.08M13.87M13.91M22.85M30.70M50.16M120.73M77.38M
短期负债 151.00K112.00K18.00K1.28M5.85M5.31M5.87M32.31M
长期负债 74.00K--10.04M8.75M25.43M27.91M46.33M26.82M
总负债 18,216,000.0015,568,000.0027,708,000.0033,118,000.0070,528,000.00101,592,000.00225,613,000.00278,033,000.00
股东权益总额 61.60M41.39M111.21M88.87M45.48M-32.03M-106.65M-28.52M
留存收益 -33.01M-30.22M-33.62M-49.64M-54.27M-110.43M-184.21M-354.14M

现金流量表

项目 2018 2019 2020 2021 2022 2023 2024 2025
经营活动现金流 -34.21M-28.40M-30.59M-47.63M-44.93M-81.61M-85.93M-104.88M
折旧与摊销 1.30M1.58M1.89M-1.29M1.70M2.60M5.20M3.22M
自由现金流 -34.76M-28.54M-30.88M-48.16M-45.49M-82.15M-86.26M-105.13M
已派股息 ----------000
股票回购/发行 32.53M8.65M101.78M25.48M8.83M30.59M57.34M206.44M
期末现金余额 56.69M35.84M105.69M86.55M86.74M26.92M96.56M99.31M

回报与效率指标

项目 2018 2019 2020 2021 2022 2023 2024 2025
净资产收益率 -53.53-58.68-44.06-49.62-80.80-1,642.63----
总资产收益率 -43.61-44.19-34.33-38.05-45.61-119.02-195.42-192.22
投入资本回报率 -53.35-58.79-41.50-45.00-60.30-251.11----
5年平均净资产收益率 -28.59-37.62-42.69-49.01-57.33-375.16----
息税前利润率 -1,043.45-431.75-9,019.35-1,171.60-440.00-598.73-1,866.96-7,150.32
自由现金流/营收 ----------------
流动比率 4.753.539.565.063.470.960.923.16
速动比率 4.643.449.104.683.160.850.903.10
资产负债率 0.280.207.248.3029.7553.8945.6723.99
长期负债权益比 0.120.009.039.9563.03------
利息保障倍数 -8,339.75-10,071.33-508.36-356.07-75.79-20.21-14.10-9.55
营收复合年增长率(3年) -13.12-9.51-57.369.4720.29260.8329.92-28.33
净利润复合年增长率(3年) ----------------
自由现金流复合年增长率(3年) ----------------

营收构成 最近报告期

业务分部

Service delivery and clinical stage research, notably into potential therapies in the areas of100.00%

地区分部

China100.00%

报价时间 2026-10-16 19:53:14 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

因文蒂瓦 讨论区 0 条评论

发表评论